Thermo Fisher Scientific Inc. (NYSE:TMO) – Jefferies Group raised their FY2016 earnings estimates for shares of Thermo Fisher Scientific in a report issued on Tuesday. Jefferies Group analyst B. Couillard now forecasts that the brokerage will earn $8.25 per share for the year, up from their prior estimate of $8.15. Jefferies Group currently has a “Hold” rating on the stock. Jefferies Group also issued estimates for Thermo Fisher Scientific’s Q4 2016 earnings at $2.43 EPS, Q1 2017 earnings at $2.02 EPS, Q2 2017 earnings at $2.29 EPS, Q4 2017 earnings at $2.66 EPS and FY2018 earnings at $10.15 EPS.

A number of other analysts also recently issued reports on TMO. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 target price for the company in a research report on Monday, August 1st. Citigroup Inc. raised their target price on Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a research report on Friday, July 29th. JPMorgan Chase & Co. began coverage on Thermo Fisher Scientific in a research report on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 target price for the company. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Thermo Fisher Scientific in a research report on Wednesday, July 6th. Finally, Mizuho set a $175.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, July 28th. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $162.72.

Earnings History and Estimates for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) traded down 0.52% during trading on Wednesday, hitting $154.09. The stock had a trading volume of 456,342 shares. The stock has a market capitalization of $60.75 billion, a P/E ratio of 30.82 and a beta of 0.97. The company has a 50-day moving average of $153.50 and a 200-day moving average of $150.90. Thermo Fisher Scientific has a 52 week low of $119.75 and a 52 week high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Thursday, July 28th. The company reported $2.03 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.02. Thermo Fisher Scientific had a return on equity of 14.70% and a net margin of 11.35%. The company earned $4.54 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the previous year, the firm earned $1.84 EPS. Thermo Fisher Scientific’s revenue was up 6.2% on a year-over-year basis.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 390 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $157.33, for a total transaction of $61,358.70. Following the completion of the sale, the director now owns 4,648 shares of the company’s stock, valued at $731,269.84. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Seth H. Hoogasian sold 5,023 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $156.00, for a total value of $783,588.00. Following the sale, the vice president now directly owns 31,914 shares of the company’s stock, valued at approximately $4,978,584. The disclosure for this sale can be found here. Company insiders own 0.52% of the company’s stock.

Large investors have recently modified their holdings of the company. Franklin Resources Inc. raised its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. Franklin Resources Inc. now owns 289,317 shares of the company’s stock valued at $40,965,000 after buying an additional 1,374 shares during the period. Botty Investors LLC increased its position in Thermo Fisher Scientific by 3.5% in the first quarter. Botty Investors LLC now owns 29,530 shares of the company’s stock valued at $4,181,000 after buying an additional 1,000 shares in the last quarter. Findlay Park Partners LLP increased its position in Thermo Fisher Scientific by 27.3% in the first quarter. Findlay Park Partners LLP now owns 967,151 shares of the company’s stock valued at $136,939,000 after buying an additional 207,151 shares in the last quarter. Nikko Asset Management Americas Inc. increased its position in Thermo Fisher Scientific by 4.8% in the first quarter. Nikko Asset Management Americas Inc. now owns 2,200 shares of the company’s stock valued at $310,000 after buying an additional 100 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Thermo Fisher Scientific by 72.3% in the first quarter. JPMorgan Chase & Co. now owns 1,953,935 shares of the company’s stock valued at $276,658,000 after buying an additional 820,110 shares in the last quarter. 87.38% of the stock is owned by hedge funds and other institutional investors.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.